Related Experiment Video
Updated: May 11, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
A novel approach to treat residual peridevice leakage after left-atrial appendage closure
Nina Wunderlich1, Neil Wilson, Horst Sievert
1CardioVascular Center, Frankfurt, Germany. info@cvcfrankfurt.de
Abstract:
Left atrial appendage (LAA) device closure has emerged as an alternative treatment to conventional anticoagaluation therapy for the prevention of thromboembolic events in patients with atrial fibrillation. In 8-10% of patients with interventional LAA obliteration, relevant residual flow into the LAA persists due to incomplete seal. We present two cases in whom for the first time two different devices were placed to complete occlusion after residual leak with a first device.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management

